Bio-Path Holdings
(NASDAQ:BPTH)
Bio-Path Holdings, Inc. - Common Stock is expected to split Monday, August 15, 2022 with a ratio of 1:5
Bio-Path Holdings, Inc. - Common Stock recently split on Friday, August 12, 2022 with a ratio of 1:3
$4.18
0.04[0.97%]
At close: Aug 12
$4.18
After Hours: 4:01PM EDT
Day High/Low4.06 - 4.24
52 Week High/Low2.68 - 4.48
Open / Close4.11 / 4.16
Float / Outstanding7.1M / 7.2M
Vol / Avg.42.7K / 36.1K
Mkt Cap29.9M
P/E-
50d Avg. Price3.86
Div / Yield-
Payout Ratio-
EPS-0.59
Total Float7.1M

Bio-Path Holdings (NASDAQ:BPTH), Quotes and News Summary

Bio-Path Holdings (NASDAQ: BPTH)

Day High/Low4.06 - 4.24
52 Week High/Low2.68 - 4.48
Open / Close4.11 / 4.16
Float / Outstanding7.1M / 7.2M
Vol / Avg.42.7K / 36.1K
Mkt Cap29.9M
P/E-
50d Avg. Price3.86
Div / Yield-
Payout Ratio-
EPS-0.59
Total Float7.1M
Sector: Health Care.Industry: Biotechnology
Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene product that is over-expressed in disease. The company's lead drug candidate, prexigebersen, is in the efficacy portion of Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. Its other drugs are BP1002 and BP1003.

Earnings

see more
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-12-20
REV
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-11-09
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Bio-Path Holdings Questions & Answers

Q
How do I buy Bio-Path Holdings (BPTH) stock?
A

You can purchase shares of Bio-Path Holdings (NASDAQ: BPTH) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Bio-Path Holdings's (BPTH) competitors?
Q
What is the target price for Bio-Path Holdings (BPTH) stock?
A

The latest price target for Bio-Path Holdings (NASDAQ: BPTH) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting BPTH to fall to within 12 months (a possible -4.31% downside). 50 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Bio-Path Holdings (BPTH)?
A

The stock price for Bio-Path Holdings (NASDAQ: BPTH) is $4.18 last updated August 12, 2022, 8:00 PM UTC.

Q
Does Bio-Path Holdings (BPTH) pay a dividend?
A

The next Bio-Path Holdings (BPTH) dividend date is projected to be Thursday, September 1, 2022.

Q
When is Bio-Path Holdings (NASDAQ:BPTH) reporting earnings?
A

Bio-Path Holdings’s FY earnings are confirmed for Wednesday, December 20, 2023.

Q
Is Bio-Path Holdings (BPTH) going to split?
A

There is no upcoming split for Bio-Path Holdings.

Q
What sector and industry does Bio-Path Holdings (BPTH) operate in?
A

Bio-Path Holdings is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.